CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Plann... ( ST. LOUIS Aug. 29 /- CMS Inc. an ...)

HOME >> MEDICINE >> TECHNOLOGY

CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System

Date:8/29/2008

ST. LOUIS, Aug. 29 /PRNewswire/ -- CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced that three sites have delivered clinical treatments utilizing Monaco(TM), its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.

Featuring biological modeling, constrained optimization, and Monte Carlo dose calculation algorithms, Monaco represents a fundamentally new approach to IMRT planning, including a unique and sophisticated set of tools to make the radiotherapy planning process easier, more straightforward and clinically reliable.

"The biologically-based Monaco IMRT treatment planning system produces clinically relevant plans, which are dosimetrically superior to plans from dose-based IMRT treatment planning systems, feature shorter plan delivery times, and can be easily verified with normal QA procedures," says Moyed Miften, Ph.D., DABR, and Allegheny General Hospital's Chief of Medical Physics. "The multi-criteria optimization and the sensitivity analysis tools in the Monaco system also help reduce the time needed to optimize IMRT plans."

While IMRT delivers significant improvements for radiation treatment, the technology presents challenges, including managing the time and resource intensive processes associated with planning. With Monaco, CMS offers new approaches that improve IMRT planning in the following ways:

-- Sensitivity Analysis tool that minimizes trial-and-error by guiding the decision making process

-- Smart Sequencing(TM), a constrained aperture optimization that produces efficient step-and-shoot segments

-- Biological models, voxel definition controls, and multi-crite
'/>"/>

0

GOOD

Page: 1 2
Related medicine technology :

1. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
2. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
3. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
4. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
5. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
6. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
7. Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
8. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
9. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
10. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
11. CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price

Post Your Comments:

CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Plann...( ST. LOUIS Aug. 29 /- CMS Inc. an ...),Health